Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases

Annals of Surgical Oncology

Volumn 9, Issue 2, 2002, Pages 148-155

  Litvak, David A ^a   Wood, Thomas F ^a   Tsioulias, George J ^a   Chung, Mathew ^a   Chawla, Sant P ^b   Foshag, Leland J ^b   Morton, Donald L ^a   Ramming, Kenneth P ^a   Bilchik, Anton J ^a,b  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b Centry City Doctors Hospital   (United States)

Author keywords

Cryosurgical ablation; Cytoreductive surgery; Floxuridine; Irinotecan; Metastatic colorectal cancer; Regional chemotherapy

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLOXURIDINE; FLUOROURACIL; IRINOTECAN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CRYOSURGERY; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CALIFORNIA; CAMPTOTHECIN; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CRYOSURGERY; DISEASE-FREE SURVIVAL; FLOXURIDINE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 0036209772     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2002.9.2.148     Document Type: Article

References (47)

1. Cancer statistics, 2001
2. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
3. Hepatic colorectal metastases: Current status of surgical therapy
4. Liver resection for colo-rectal metastases
5. A 5-year study of cryosurgery in the treatment of liver tumors
6. Natural history of patients with untreated liver metastases from colorectal cancer
7. Prognosis of carcinoma of the large bowel in the presence of liver metastases
8. Surgical therapy of hepatic colorectal metastases
9. Treatment of colorectal liver metastases by cryotherapy
10. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer
11. A collective review of the world literature on hepatic cryotherapy
12. Long-term survival after hepatic cryosurgery versus surgical resection for metastatic colorectal carcinoma: A critical review of the literature
13. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU
14. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study
15. 5-Fluorouracil (5-FU), methyl-CCNU and vincristine in the treatment of advanced colorectal cancer: Phase II study utilizing weekly 5-FU
16. 5 FU infusion with mitomycin-C versus 5 FU infusion with methyl-CCNU in the treatment of advanced colon cancer: Southwest Oncology Group study
17. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
18. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
19. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases
20. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial
21. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial
22. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries
23. Update on hepatic intra-arterial chemotherapy
24. Phase II study of CPT- 11, a new camptothecin derivative, in metastatic colorectal cancer
25. A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma
26. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
27. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
28. Biochemical modulation of fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma
29. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously treated patients with advanced colorectal carcinoma
30. Surgical options in the treatment of hepatic metastasis from colorectal cancer
31. Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications
32. Cryosurgery and radiofrequency ablation for unresectable hepatic malignancies: A proposed algorithm
33. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients
34. Complications of hepatic cryosurgery
35. Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil
36. Intra-arterial floxuridine vs. systemic fluorouracil for hepatic metastases from colorectal cancer
37. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature
38. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folic acid for liver metastases of colorectal cancer
39. Phase II study of hepatic fluorouridine, leucovorin and dexamethasone for unresectable liver metastases from colorectal carcinoma
40. A prospective randomized evaluation of the treatment of colorectal cancer metastatic to the liver
41. Quantification of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers
42. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer
43. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
44. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection
45. Hepatic resection for metastases of the colon and rectum
46. CEA reduction after cryotherapy for liver metastases from colon cancer predicts survival
47. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy